Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Hermans

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Pharmacological Research|August 29, 2020
Regulators of G protein signalling as pharmacological targets for the treatment of neuropathic painPierre J Doyen, Pauline Beckers, Gary A Brook, et al.
Glia|December 22, 2017
Constitutive downregulation protein kinase C epsilon in hSOD1<sup>G93A</sup> astrocytes influences mGluR5 signaling and the regulation of glutamate uptakeMaxime Vergouts, Pierre J Doyen, Michael Peeters, et al.
Journal of Neurochemistry|December 11, 2012
Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell deathStéphanie De Simoni, Dominique Linard, Emmanuel Hermans, et al.
European Journal of Pharmacology|June 29, 2004
Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptorsSophie J Govaerts, Giulio G Muccioli, Emmanuel Hermans, et al.
Neurochemistry International|December 12, 2001
Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cellsGuylène Page, Sylvie Chalon, Patrick Emond, et al.
Journal of Neurochemistry|June 2, 2007
Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell lineBarbara Bosier, Sébastien Tilleux, Mustapha Najimi, et al.
Journal of Neuroscience Research|March 10, 2009
Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosisCédric Boucherie, Sabrina Schäfer, Patricia Lavand'homme, et al.
Neuropharmacology|January 13, 2022
Dopamine D<sub>2</sub>L receptor density influences the recruitment of β-arrestin2 and G<sub>i</sub>1 induced by antiparkinsonian drugsMattia Ferraiolo, Hicham Atik, Romane Ponthot, et al.
Fundamental & Clinical Pharmacology|June 29, 2022
Receptor density influences the recruitment bias of aripiprazole and brexpiprazole at the dopamine D<sub>2L</sub> receptorMattia Ferraiolo, Romane Ponthot, Hicham Atik, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 30, 2011
Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazoleBeryl Koener, Marylène C Focant, Barbara Bosier, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Pharmacological Research|August 29, 2020
Regulators of G protein signalling as pharmacological targets for the treatment of neuropathic painPierre J Doyen, Pauline Beckers, Gary A Brook, et al.
Glia|December 22, 2017
Constitutive downregulation protein kinase C epsilon in hSOD1<sup>G93A</sup> astrocytes influences mGluR5 signaling and the regulation of glutamate uptakeMaxime Vergouts, Pierre J Doyen, Michael Peeters, et al.
Journal of Neurochemistry|December 11, 2012
Mitochondrial peroxiredoxin-5 as potential modulator of mitochondria-ER crosstalk in MPP+-induced cell deathStéphanie De Simoni, Dominique Linard, Emmanuel Hermans, et al.
European Journal of Pharmacology|June 29, 2004
Characterization of the pharmacology of imidazolidinedione derivatives at cannabinoid CB1 and CB2 receptorsSophie J Govaerts, Giulio G Muccioli, Emmanuel Hermans, et al.
Neurochemistry International|December 12, 2001
Pharmacological characterisation of (E)-N-(3-iodoprop-2-enyl)-2beta-carbomethoxy-3beta-(4'-methylphenyl)nortropane (PE2I) binding to the rat neuronal dopamine transporter expressed in COS cellsGuylène Page, Sylvie Chalon, Patrick Emond, et al.
Journal of Neurochemistry|June 2, 2007
Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell lineBarbara Bosier, Sébastien Tilleux, Mustapha Najimi, et al.
Journal of Neuroscience Research|March 10, 2009
Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosisCédric Boucherie, Sabrina Schäfer, Patricia Lavand'homme, et al.
Neuropharmacology|January 13, 2022
Dopamine D<sub>2</sub>L receptor density influences the recruitment of β-arrestin2 and G<sub>i</sub>1 induced by antiparkinsonian drugsMattia Ferraiolo, Hicham Atik, Romane Ponthot, et al.
Fundamental & Clinical Pharmacology|June 29, 2022
Receptor density influences the recruitment bias of aripiprazole and brexpiprazole at the dopamine D<sub>2L</sub> receptorMattia Ferraiolo, Romane Ponthot, Hicham Atik, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 30, 2011
Increasing the density of the D2L receptor and manipulating the receptor environment are required to evidence the partial agonist properties of aripiprazoleBeryl Koener, Marylène C Focant, Barbara Bosier, et al.
Pageof 11